Edie Stringfellow | SVP, Global Health Strategy & Biomedical Commercialization
Precia Group

Edie Stringfellow brings two decades of experience in public policy, global health equity, ecosystem development, and clinical research to her role as SVP Global Health Strategy & Biomedical Commercialization at Precia Group. She is committed to establishing Precia Group as a front-runner in women’s health research and global health equity initiatives with the goal of positioning Precia Group as an essential hub for addressing clinical trial challenges in women’s health within the biopharma industry, both domestically and internationally.   Throughout her career, Edie has held notable positions such as Vice President of Ecosystem Development at the Center for Global Health Innovation; Senior Director at the Massachusetts Biotechnology Council; Strategic Executive Advisor at Biocom California; and Director of Patient Recruitment & Retention at ClinEdge. Leveraging her strategic expertise, Edie aims to cultivate new business avenues and foster global partnerships to drive the organization’s mission forward.   Edie co-founded the LS-VAN (Life Sciences Veterans Action Network) and affiliated WITH Boston Chapter (Women Innovating Together in Healthcare). Notably, she championed the “CEO Pledge to Racial Equity in BioPharma,” earning widespread endorsement from industry leaders. Edie’s impactful contributions to public policy advocacy have resulted in resolutions backed by esteemed organizations like the National Black Caucus of State Legislators.   Edie holds a BSc from Illinois State University and and a MSc from Boston College. Beyond her professional pursuits, she finds joy in collaborating on sports/film/entertainment STEM-related productions. Her daughter, Cheyenne, a Pre-Med Neuroscience student at the University of Miami, aspires to become a neurotrauma researcher and screenwriter.